No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABT240726P105000
- 3.45
- -1.73-33.40%
15min DelayClose Jul 19 15:59 ET
3.79High3.45Low
3.79Open5.18Pre Close5 Volume332 Open Interest105.00Strike Price1.80KTurnover28.00%IV0.47%PremiumJul 26, 2024Expiry Date2.97Intrinsic Value100Multiplier4DDays to Expiry0.48Extrinsic Value100Contract SizeAmericanOptions Type-0.8057Delta0.0860Gamma31.25Leverage Ratio-0.0838Theta-0.0088Rho-25.18Eff Leverage0.0323Vega
Intraday
- 5D
- Daily
News
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories (NYSE:ABT) CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device.This
Morgan Stanley Maintains Abbott Laboratories(ABT.US) With Hold Rating, Maintains Target Price $107
Morgan Stanley analyst Patrick Wood maintains $Abbott Laboratories(ABT.US)$ with a hold rating, and maintains the target price at $107.According to TipRanks data, the analyst has a success rate of 50.
Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)
What Are the Most Profitable Stocks of All Time? The Answer Might Surprise You.
An academic with a large following on Wall Street recently published a paper showing the stocks that have seen the strongest returns over time
Nephron Adjusts Price Target on Abbott Laboratories to $110 From $115
Abbott Laboratories (ABT) has an average outperform rating and a price target range of $104 to $143, according to analysts polled by Capital IQ.Price: 100.45, Change: +0.38, Percent Change: +0.38
Comments
The earnings season is picking up speed, and this mid-July, we're about to get updates from some of the biggest names across various industries. Expect to hear from large banks, healthcare companies, airlines, and some of the tech and telecom giants that we all know.
The season started off last Friday with $JPMorgan(JPM.US$ , $Wells Fargo & Co(WFC.US$ , and $Wells Fargo & Co(WFC.US$ sharing their numbers. They all did bett...
The season started off last Friday with $JPMorgan(JPM.US$ , $Wells Fargo & Co(WFC.US$ , and $Wells Fargo & Co(WFC.US$ sharing their numbers. They all did bett...
+3
23
$Abbott Laboratories(ABT.US$
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
1
$Abbott Laboratories(ABT.US$
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
2
Morning Movers
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
31
Read more